Survival from locally invasive or widespread neuroblastoma without cytotoxic therapy Academic Article uri icon

Overview

MeSH Major

  • Neuroblastoma

abstract

  • Our results suggest that non-stage 4 patients without N-myc amplification can be spared cytotoxic therapy because (1) residual postsurgical or recurrent biologically favorable neuroblastoma rarely evolves into lethal stage 4 disease; and (2) neuroblastoma in lymph nodes has no prognostic significance. These findings are remarkable because no other cancer includes subtypes that are curable without therapy to ablate residual disease.

publication date

  • February 1996

Research

keywords

  • Academic Article

Identity

Language

  • eng

PubMed ID

  • 8636746

Additional Document Info

start page

  • 373

end page

  • 81

volume

  • 14

number

  • 2